Get startedLog in
    Picture of Alligator Bioscience AB logo

    ATORX — Alligator Bioscience AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Alligator Bioscience: Data Confirm Mitazalimab's Manageable Safety Profile

    Picture of Alligator Bioscience AB logoAlligator Bioscience AB
    22/12/2022 08:36
    Dec 22 (Reuters) - Alligator Bioscience AB  ATORX.ST :
    * ANNOUNCES PUBLICATION HIGHLIGHTING PHASE 1 MITAZALIMAB
DATA IN
SOLID TUMORS
    * DATA CONFIRM MITAZALIMAB'S MANAGEABLE SAFETY PROFILE VIA A
THOROUGH DOSE-ESCALATION APPROACH VIA INTRAVENOUS ADMINISTRATION

Source text for Eikon:  ID:nMFN7ssv4v 
Further company coverage:  ATORX.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Alligator Bioscience AB

    See all news